3D printed drugs are drugs manufactured by solidifying layers of materials to form a definite 3D structure. The adaptability of 3D printing is also applied for the precise and unique dosing of medicines, to present more efficient drug administration. 3D printing is expected to be an efficient method to enhance the application of several controlled drug release mechanisms, during the forecast period.
The global 3D printed drugs market growth is driven by several factors such as rising healthcare disorders globally and rising demand for cheaper drugs or pills 12qazx and increasing adaptability of 3D printing in the medical industries. With rising awareness towards the advantages of 3D printed drugs, such as their instantaneous solubility.
In addition, the increasing advancements in 3D printing technology and the rising investments to increase the research activities for the development of highly efficient 3D printed drugs are also expected to boost the growth of the market during the forecast period. For instance, in December 2017, Aprecia and Cycle Pharmaceuticals from Cambridge in the UK announced a partnership to develop and commercialize 3D printed tablets for orphan (rare) diseases using the ZipDose technology. In 2015, the Howard Hughes Medical Institute developed a molecular 3D printer for formulating new drugs by synthesizing blocks of small molecules from the basic chemical pattern.
Market Dynamics
Drivers
- Growing advancements in 3D printing technology and rising investments
- Advantages of 3D printing over traditional method
- Growing prevalence of epilepsy
Restraints
- Stringent regulatory approvals
- Challenges faced with printers and inks required for printing drugs
Advantages Of 3d Printing Over Traditional Method
There are several benefits of 3D technology in compounding pharmacies which is expected to drive the growth of the 3D printed drugs market over the forecast period. For instance, 3D technology has the ability to create tablets of any shape and size and ability to set the dosage individually for each patient.
Also, 3D technology has the ability to regulate the number of active substances in the composition of the tablet, remove or replace individual components. This will help many people take medicine even if there are contraindications to a single substance.
We can replace a large number of drugs with one tablet by 3D technology, which also reduces the frequency of medication. There is a larger availability of drugs that can be obtained at any pharmacy with a 3D printer if a patient has a doctor’s prescription.
Moreover, the production is eco-friendly as in the manufacturing process of tablets with a 3D printer, no waste pollutes the environment.
When compared to traditional methods, 3D printing has the ability to print small batches of drugs, saving money on the production and testing of drugs. Also, the manufacture of tablets on a 3D printer eliminates the possibility to mix up drugs or take other patient’s tablets by mistake.
Apart from all these benefits, mini-factories for the production of tablets can be in each local region. Such printers can even be installed in military hospitals and taken on space expeditions. This can help patients to get appropriate medications even during a pandemic, natural disaster or other events.
Geographical Analysis
Asia Pacific is expected to grow at a high growth rate in the coming years. The growth of the market is due to the increasing research activities, rising prevalence of various diseases such as epilepsy and growing government initiatives are the major factors which are driving the growth of the market in the region.
For instance, according to WHO, epilepsy affects about 1% of the population of the South-East Asia Region. Approximately 15 million people with epilepsy are only in South-East Asia. These factors have boosted the development of 3D printed pharmaceuticals for the cure of the disease.
Chinese pharmaceutical companies are constantly working on the development of 3D pharmaceuticals. Also these companies are supported by the government of China.
For instance, in February 9, 2021, Triastek, Inc. a pharmaceutical company specializing in 3D printing of drug products, announced that the United States Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) 505(b)(2) application for its first 3D printed drug product – T19, indicated for the treatment of rheumatoid arthritis (RA). Developed in-house, Triastek has global intellectual property rights to the T19 3D printed formulation.
Triastek plans to apply for IND approval in China in the year 2021, followed by applications in Japan and Europe. The New Drug Application of T19 is expected to be filed to the U.S. FDA in 2023. Following T19, Triastek has developed 505(b)(2) product portfolio to meet specific clinical needs and improve the outcomes of drug therapy using MED TM 3D printing technology.
In addition, Indian companies are also trying to develop 3D printed drugs in the country. However, these are in their starting phase. This is mainly due to continuous innovations and technological advancement in the field of pharmaceutical drugs.
However, this technology may be misused by counterfeit or illegal drug manufacturers. The 3D printers and its technology and printing software can be tampered with and be used to manufacture or mask illegal drugs in a huge scale. The cyber hackers can gain access to any innovators software and it can be used to make illegal pharmaceuticals.
In Asia Pacific, the drug regulation authorities of countries have to form strict rules and regulations to ensure the manufacturing and marketing of 3D printed drugs will be safe and reliable.
The potential is large, but it will take many years for it to gain strong commercial traction in the proper development, trials, and commercial availability of 3D printed drugs in the region.
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
